HIFS
Hingham Institution for Savings
HIFS's fundamentals are strong: its operating margin rose 15 points to 36% and revenue grew 13%. At 10x earnings, it's trading below its usual 13x.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
HIFS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
HIFS's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HIFS.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
HIFS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $301 | — |
| Cheap | 11x | $322 | +7% |
| Fair | 13x | $380 | +26% |
| Expensive | 19x | $570 | +90% |
Historical ranges are pointers, not guarantees.
HIFS's PE is in its cheap range at 10x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
HIFS Forward outlook
There aren't enough analyst estimates for HIFS to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HIFS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $30.02 | +95% |
| Q1 2026 | $22.81 | +76% |
| Q4 2025 | $24.76 | +93% |
| Q3 2025 | $20.55 | +95% |
| Q2 2025 | $15.36 | +63% |
| Q1 2025 | $12.96 | +15% |
| Q4 2024 | $12.85 | +6.9% |
| Q3 2024 | $10.56 | -28% |
HIFS has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
HIFS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $72M | +33% |
| Q1 2026 | $42.1M | -18% |
| Q4 2025 | $66.8M | +14% |
| Q3 2025 | $64.5M | +21% |
| Q2 2025 | $54.1M | +4.5% |
| Q1 2025 | $51.4M | -4.3% |
| Q4 2024 | $58.7M | +12% |
| Q3 2024 | $53.2M | +16% |
HIFS's revenue is growing: $72M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 46% | +23 points |
| Q1 2026 | 10% | -9.2 points |
| Q4 2025 | 40% | +15 points |
| Q3 2025 | 36% | +21 points |
| Q2 2025 | 24% | +13 points |
| Q1 2025 | 19% | +4.2 points |
| Q4 2024 | 26% | +10 points |
| Q3 2024 | 15% | +4.9 points |
HIFS has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
HIFS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.6M | -34% |
| Q1 2026 | $13.1M | +15% |
| Q4 2025 | $7.5M | +385% |
| Q3 2025 | $11.1M | +208% |
| Q2 2025 | $5.4M | +89% |
| Q1 2025 | $11.5M | +208% |
| Q4 2024 | $1.6M | -63% |
| Q3 2024 | $3.6M | -33% |
HIFS has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
HIFS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +4K shares |
| 1 year | +0.6% | +13K shares |
| 3 years | +1% | +22K shares |
| 5 years | +0.6% | +12.4K shares |
| Available history | +1.4% | +30K shares |
HIFS has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HIFS hasn't bought back shares in the past year.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HIFS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 15.8x | High |
| Q1 2026 | 20.7x | High |
| Q4 2025 | 19.8x | High |
| Q3 2025 | 18.9x | High |
| Q2 2025 | 26.2x | High |
| Q1 2025 | 28.4x | High |
| Q4 2024 | 30.7x | High |
| Q3 2024 | 38.2x | High |
HIFS has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
HIFS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.3 | Neutral |
| Stochastic | 44.0 | Neutral |
HIFS's weekly RSI is 52 (neutral) and its Stochastic is 44 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
HIFS PE vs Financial Services Sector
| Metric | HIFS | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 23% below |
| PE % | 10 | 63 | 53 pts below |
HIFS is trading at 10x earnings, a 23% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
HIFS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $296.3 | 1.5% above |
| 20 week MA | $298.3 | 0.8% above |
| 50 week MA | $293.2 | 2.5% above |
| 100 week MA | $275.4 | 9.2% above |
| 200 week MA | $242.8 | 24% above |
HIFS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
HIFS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $209.9 | $216.2 | +3% |
| 2021 | $216.2 | $391.5 | +81% |
| 2022 | $391.5 | $276.3 | -29% |
| 2023 | $276.3 | $194.4 | -30% |
| 2024 | $194.4 | $253.1 | +30% |
| 2025 | $253.1 | $291.2 | +15% |
| 2026 YTD | $291.2 | $300.6 | +3.2% |
HIFS has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.